Matches 1 - 19 out of 19
Match Document Document Title
7608635 Pyrazole compounds that modulate HSP90 activity  
Compounds of formula (I), pharmaceutical compositions comprising compounds of formula (I) and methods of inhibiting Hsp90 in a cell, treating or preventing a proliferation disorder in a mammal and...
7598389 Silylated carboxamides  
Novel silylated carboxamides of the formula (I) in which R, L, R 1 , R 3 , R 3 , R 4 and A are as defined in the description, a plurality of processes for preparing these compounds and their...
7576116 PDK-1/Akt signaling inhibitors  
A new class of phosphoinositide-dependent kinase-1 (PDK-1) inhibitors of formula I: wherein X is selected from the group consisting of alkyl and haloalkyl; Ar is an aryl radical selected from...
7576115 Heterocyclic compounds and thrombopoietin receptor activators  
A compound represented by the formula (1): wherein A is a nitrogen atom or CR 4 , B is an oxygen atom, a sulfur atom or NR 9 (provided that when A is a nitrogen atom, B is not NH), R 1 is a C...
7572797 Amino substituted pyrazine derivatives for the treatment of pain  
The present invention relates to compounds of the formula and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation...
7569516 Plant growth regulation  
The present invention relates to a new class of plant growth regulators. In particular, the invention relates to 5-substituted-1-arylpyrazole-3-carboxylic acid derivative of general formula (I) and...
7566716 Imidazopyrazines as Raf inhibitor compounds  
Compounds of Formula I are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using compounds of Formula I, and stereoisomers, tautomers, solvates and...
7538134 Substituted arylpyrazoles  
This invention relates to a range of 1-aryl-4-cyclopropylpyrazoles in which the cyclopropyl ring is substituted at the angular position, and pharmaceutically acceptable salts and solvates thereof,...
7528260 Method for preparing N-phenylpyrazole-1-carboxamides  
A method is disclosed for preparing compounds of Formula 1 by combining compounds of Formulae 2 and 3 and a sulfonyl chloride. Also disclosed are compounds of Formula 3, which are useful as...
7521471 4-cyanopyrazole-3-carboxamide derivatives, preparation and application thereof  
The invention relates to 4-cyanopyrazole-3-carboxamide derivatives of formula (I): in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 are as described herein. Also disclosed and claimed...
7511149 Process for the oxidation of certain substituted sulfilimines to insecticidal sulfoximines  
Insecticidal sulfoximines are produced efficiently and in high yield by the oxidation of the corresponding sulfilimine with ruthenium tetraoxide or an alkali metal permanganate.
7511034 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses  
Novel dialkylhydroxybenzoic acid derivatives containing metal chelating groups are disclosed. The novel compounds are used as therapeutics for treating and/or preventing various medical...
7504518 Process for producing blocked isocyanate compound  
Disclosed is a process for producing a blocked isocyanate compound represented by general formula (III): wherein R 1 , R 2 , Q 1 , and Q 2 are as defined in the specification, characterized by...
7495017 Phosphodiesterase 4 inhibitors  
Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with...
7476687 Substituted furo[2,3-g]indazoles for the treatment of glaucoma  
Substituted furo[2,3-g]indazoles for lowering intraocular pressure and treating glaucoma are disclosed.
7452899 Gamma-secretase inhibitors  
Compounds of Formula (I): inhibit the processing of APP by gamma-secretase, and hence are useful for treatment or prevention of Alzheimer's disease.
7446121 Pyrazole-based HMG CoA reductase inhibitors  
Novel compounds and pharmaceutical compositions useful as hypocholesterolemic and hypolipidemic agents are described. More specifically, potent inhibitors of the enzyme...
7417151 Boron-based organic cations and related methods  
Generally disclosed are boron-based organic cations, a method for their manufacture, a method for their use in ionic liquids, and a method for their use as phase-transfer catalysts. More...
7396850 Pyrazole derivative as PPAR modulator  
The present invention is directed to a compound, {2-Methyl-4-[3-methyl-1-(4-trifluoromethyl-phenyl)-1H-pyrazo l-4-ylmethylsulfanyl]-phenoxy}-acetic acid and pharmaceutical uses thereof.
Matches 1 - 19 out of 19